{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:29:15Z","timestamp":1792531755480,"version":"4.5.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"Supplement_I","license":[{"start":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T00:00:00Z","timestamp":1668211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiac magnetic resonance (CMR) is a non-invasive imaging method that allows to characterize myocardial tissue. In particular, using the late gadolinium enhancement technique, it is possible to identify areas of focal fibrosis. Specific distribution patterns of this fibrosis allow us to distinguish ischaemic cardiomyopathy (iCMP) from non-ischaemic cardiomyopathy (nCMP) and sometimes to identify the aetiology of the latter. Diffuse fibrosis can also be identified using the parametric T1 mapping sequences. For this purpose, the native T1 of the tissue is measured before the administration of the contrast agent (c.a.) or the extracellular volume is calculated after c.a. Both focal and diffuse fibrosis evaluated with CMR appear to be strong prognostic predictors for the identification of threatening ventricular arrhythmias and sudden cardiac death. These evidence open the doors to a possible role of CMR in the selection of the patient to be sent to a defibrillator implant in primary prevention. In this review, we will briefly review the techniques used in CMR for the evaluation of fibrosis. We will then focus on the clinical role of myocardial tissue fibrosis detection in iCMP and nCMP.<\/jats:p>","DOI":"10.1093\/eurheartjsupp\/suac085","type":"journal-article","created":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T10:19:23Z","timestamp":1668248363000},"page":"I123-I126","source":"Crossref","is-referenced-by-count":11,"title":["Clinical implications of cardiac magnetic resonance imaging fibrosis"],"prefix":"10.1093","volume":"24","author":[{"given":"Marco","family":"Guglielmo","sequence":"first","affiliation":[{"name":"Department of Cardiology, Division of Heart and Lungs, Utrecht University, Utrecht University Medical Center , Utrecht , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Pontone","sequence":"additional","affiliation":[{"name":"Monzino Cardiology Center IRCCS , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,11,12]]},"reference":[{"key":"2022111417531034300_suac085-B1","article-title":"Clinical application of CMR in cardiomyopathies: evolving concepts and techniques: a position paper of myocardial and pericardial diseases and cardiac magnetic resonance working groups of Italian society of cardiology","author":"Merlo","journal-title":"Heart Fail Rev"},{"key":"2022111417531034300_suac085-B2","doi-asserted-by":"crossref","first-page":"9254","DOI":"10.1007\/s12410-013-9254-9","article-title":"Myocardial tissue characterization: histological and pathophysiological correlation","volume":"7","author":"Treibel","year":"2014","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"2022111417531034300_suac085-B3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.tcm.2020.08.001","article-title":"Current evidence on the diagnostic and prognostic role of native T1 mapping in heart diseases","volume":"31","author":"Tonet","year":"2021","journal-title":"Trends Cardiovasc Med"},{"key":"2022111417531034300_suac085-B4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/RTI.0000000000000270","article-title":"Cardiac magnetic resonance T1-mapping of the myocardium: technical background and clinical relevance","volume":"33","author":"Muscogiuri","year":"2018","journal-title":"J Thorac Imaging"},{"key":"2022111417531034300_suac085-B5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11886-017-0907-1","article-title":"Role of cardiac magnetic resonance imaging in myocardial infarction","volume":"19","author":"Pontone","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"2022111417531034300_suac085-B6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/RTI.0000000000000621","article-title":"Cardiac magnetic resonance tissue characterization in ischemic cardiomyopathy","volume":"37","author":"Muscogiuri","year":"2022","journal-title":"J Thorac Imaging"},{"key":"2022111417531034300_suac085-B7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/ehjci\/jez179","article-title":"Early or deferred cardiovascular magnetic resonance after ST-segment-elevation myocardial infarction for effective risk stratification","volume":"21","author":"Masci","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022111417531034300_suac085-B8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","article-title":"The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction","volume":"343","author":"Kim","year":"2000","journal-title":"N Engl J Med"},{"key":"2022111417531034300_suac085-B9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.004956","article-title":"Prognostic benefit of cardiac magnetic resonance over transthoracic echocardiography for the assessment of ischemic and nonischemic dilated cardiomyopathy patients referred for the evaluation of primary prevention implantable cardioverter-defibrillator therapy","volume":"9","author":"Pontone","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2022111417531034300_suac085-B10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/ehjci\/jeu024","article-title":"T1 mapping in ischaemic heart disease","volume":"15","author":"h-Ici","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022111417531034300_suac085-B11","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1093\/eurheartj\/suab105","article-title":"Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging","volume":"23","author":"Guglielmo","year":"2021","journal-title":"Eur Heart J Suppl"},{"key":"2022111417531034300_suac085-B12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jacc.2018.05.060","article-title":"Late gadolinium enhancement in patients with hypertrophic cardiomyopathy and preserved systolic function","volume":"72","author":"Mentias","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2022111417531034300_suac085-B13","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022111417531034300_suac085-B14","article-title":"Role of CMR mapping techniques in cardiac hypertrophic phenotype","volume":"10","author":"Baggiano","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"2022111417531034300_suac085-B15","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.jcmg.2018.07.015","article-title":"Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement","volume":"12","author":"Halliday","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022111417531034300_suac085-B16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcmg.2015.12.001","article-title":"T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure","volume":"9","author":"Puntmann","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022111417531034300_suac085-B17","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2022111417531034300_suac085-B18","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"2022111417531034300_suac085-B19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacc.2005.11.045","article-title":"Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study","volume":"47","author":"Stecker","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2022111417531034300_suac085-B20","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/europace\/euaa401","article-title":"CarDiac magnEtic resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: an international registry","volume":"23","author":"Guaricci","year":"2021","journal-title":"Europace"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/24\/Supplement_I\/I123\/47030512\/suac085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/24\/Supplement_I\/I123\/47030512\/suac085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T21:50:22Z","timestamp":1728337822000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/24\/Supplement_I\/I123\/6823814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,12]]},"references-count":20,"journal-issue":{"issue":"Supplement_I","published-online":{"date-parts":[[2022,11,12]]},"published-print":{"date-parts":[[2022,11,12]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartjsupp\/suac085","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,12]]},"published":{"date-parts":[[2022,11,12]]}}}